Akahata, W., Z. Y. Yang, H. Andersen, S. Sun, H. A. Holdaway, W. P. Kong, M. G. Lewis, S. Higgs, M. G. Rossmann, S. Rao and G. J. Nabel (2010). "A virus-like particle vaccine for epidemic Chikungunya virus protects nonhuman primates against infection." Nat Med 16(3): 334-338.



Alexander, M., R. Lynch, J. Mulenga, S. Allen, C. A. Derdeyn and E. Hunter (2010). "Donor and recipient envs from heterosexual human immunodeficiency virus subtype C transmission pairs require high receptor levels for entry." J Virol 84(8): 4100-4104.



Astronomo, R. D. and D. R. Burton (2010). "Carbohydrate vaccines: developing sweet solutions to sticky situations?" Nat Rev Drug Discov 9(4): 308-324.



Astronomo, R. D., E. Kaltgrad, A. K. Udit, S.-K. Wang, K. J. Doores, C.-Y. Huang, R. Pantophlet, J. C. Paulson, C.-H. Wong, M. G. Finn and D. R. Burton (2010). "Defining Criteria for Oligomannose Immunogens for HIV Using Icosahedral Virus Capsid Scaffolds." Chemistry & Biology 17(4): 357-370.



Bahati, P., W. Kidega, H. Ogutu, J. Odada, B. Bender, P. Fast , J. Becker and M. A. Price (2010). "Ensuring quality of services in HIV prevention research settings: findings from a multi-center quality improvement pilot in East Africa." AIDS Care 22(1): 119-125.



Bere, A., L. Denny, W. Hanekom, W. A. Burgers and J. A. Passmore (2010). "Comparison of polyclonal expansion methods to improve the recovery of cervical cytobrush-derived T cells from the female genital tract of HIV-infected women." J Immunol Methods 354(1-2): 68-79.



Bhattacharyya, S., R. E. Rajan, Y. Swarupa, U. Rathore, A. Verma, R. Udaykumar and R. Varadarajan (2010). "Design of a non-glycosylated outer domain-derived HIV-1 gp120 immunogen that binds to CD4 and induces neutralizing antibodies." J Biol Chem 285(35): 27100-27110.



Binley, J. M., Y. E. Ban, E. T. Crooks, D. Eggink, K. Osawa, W. R. Schief and R. W. Sanders (2010). "Role of complex carbohydrates in human immunodeficiency virus type 1 infection and resistance to antibody neutralization." J Virol 84(11): 5637-5655.



Burton, D. R. (2010). "Scaffolding to build a rational vaccine design strategy." Proc Natl Acad Sci U S A 107(42): 17859-17860.



Burton, D. R. and R. A. Weiss (2010). "AIDS/HIV. A boost for HIV vaccine design." Science 329(5993): 770-773.



Celum, C., A. Wald, J. R. Lingappa, A. S. Magaret, R. S. Wang, N. Mugo, A. Mujugira, J. M. Baeten, J. I. Mullins, J. P. Hughes, E. A. Bukusi, C. R. Cohen, E. Katabira, A. Ronald, J. Kiarie, C. Farquhar, G. J. Stewart, J. Makhema, M. Essex, E. Were, K. H. Fife, G. de Bruyn, G. E. Gray, J. A. McIntyre, R. Manongi, S. Kapiga, D. Coetzee, S. Allen, M. Inambao, K. Kayitenkore, E. Karita, W. Kanweka, S. Delany, H. Rees, B. Vwalika, W. Stevens, M. S. Campbell, K. K. Thomas, R. W. Coombs, R. Morrow, W. L. Whittington, M. J. McElrath, L. Barnes, R. Ridzon, L. Corey and H. S. V. H. I. V. T. S. T. Partners in Prevention (2010). "Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2." N Engl J Med 362(5): 427-439.



Cerutti, N., B. V. Mendelow, G. B. Napier, M. A. Papathanasopoulos, M. Killick, M. Khati, W. Stevens and A. Capovilla (2010). "Stabilization of HIV-1 gp120-CD4 receptor complex through targeted interchain disulfide exchange." J Biol Chem 285(33): 25743-25752.



Conkling, M., E. L. Shutes, E. Karita, E. Chomba, A. Tichacek, M. Sinkala, B. Vwalika, M. Iwanowski and S. A. Allen (2010). "Couples' voluntary counselling and testing and nevirapine use in antenatal clinics in two African capitals: a prospective cohort study." J Int AIDS Soc 13: 10.



Council of the Global, H. I. V. V. E. (2010). "The 2010 scientific strategic plan of the Global HIV Vaccine Enterprise." Nat Med 16(9): 981-989.



Donnell, D., J. M. Baeten, J. Kiarie, K. K. Thomas, W. Stevens, C. R. Cohen, J. McIntyre, J. R. Lingappa, C. Celum and H. S. V. H. I. V. T. S. T. Partners in Prevention (2010). "Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis." Lancet 375(9731): 2092-2098.



Doores, K. J., C. Bonomelli, D. J. Harvey, S. Vasiljevic, R. A. Dwek, D. R. Burton, M. Crispin and C. N. Scanlan (2010). "Envelope glycans of immunodeficiency virions are almost entirely oligomannose antigens." Proc Natl Acad Sci U S A 107(31): 13800-13805.



Doores, K. J. and D. R. Burton (2010). "Variable loop glycan dependency of the broad and potent HIV-1-neutralizing antibodies PG9 and PG16." J Virol 84(20): 10510-10521.



Doores, K. J., Z. Fulton, V. Hong, M. K. Patel, C. N. Scanlan, M. R. Wormald, M. G. Finn, D. R. Burton, I. A. Wilson and B. G. Davis (2010). "A nonself sugar mimic of the HIV glycan shield shows enhanced antigenicity." Proc Natl Acad Sci U S A 107(40): 17107-17112.



Doores, K. J., Z. Fulton, M. Huber, I. A. Wilson and D. R. Burton (2010). "Antibody 2G12 recognizes di-mannose equivalently in domain- and nondomain-exchanged forms but only binds the HIV-1 glycan shield if domain exchanged." J Virol 84(20): 10690-10699.



Douagi, I., M. N. Forsell, C. Sundling, S. O'Dell, Y. Feng, P. Dosenovic, Y. Li, R. Seder, K. Lore, J. R. Mascola, R. T. Wyatt and G. B. Karlsson Hedestam (2010). "Influence of novel CD4 binding-defective HIV-1 envelope glycoprotein immunogens on neutralizing antibody and T-cell responses in nonhuman primates." J Virol 84(4): 1683-1695.



Dunlop, D. C., C. Bonomelli, F. Mansab, S. Vasiljevic, K. J. Doores, M. R. Wormald, A. S. Palma, T. Feizi, D. J. Harvey, R. A. Dwek, M. Crispin and C. N. Scanlan (2010). "Polysaccharide mimicry of the epitope of the broadly neutralizing anti-HIV antibody, 2G12, induces enhanced antibody responses to self oligomannose glycans." Glycobiology 20(7): 812-823.



Eggink, D., M. Melchers, M. Wuhrer, T. van Montfort, A. K. Dey, B. A. Naaijkens, K. B. David, V. Le Douce, A. M. Deelder, K. Kang, W. C. Olson, B. Berkhout, C. H. Hokke, J. P. Moore and R. W. Sanders (2010). "Lack of complex N-glycans on HIV-1 envelope glycoproteins preserves protein conformation and entry function." Virology 401(2): 236-247.



Excler, J. L., C. L. Parks, J. Ackland, H. Rees, I. D. Gust and W. C. Koff (2010). "Replicating viral vectors as HIV vaccines: summary report from the IAVI-sponsored satellite symposium at the AIDS vaccine 2009 conference." Biologicals 38(4): 511-521.



Fast, P. E. and P. Kaleebu (2010). "HIV vaccines: current status worldwide and in Africa." AIDS 24 Suppl 4: S50-60.



Fast, P. E. and P. Kaleebu (2010). "HIV vaccines: current status worldwide and in Africa." AIDS 24 Suppl 4(Suppl 4): S50-60.



Finzi, A., B. Pacheco, X. Zeng, Y. D. Kwon, P. D. Kwong and J. Sodroski (2010). "Conformational characterization of aberrant disulfide-linked HIV-1 gp120 dimers secreted from overexpressing cells." J Virol Methods 168(1-2): 155-161.



Finzi, A., S. H. Xiang, B. Pacheco, L. Wang, J. Haight, A. Kassa, B. Danek, M. Pancera, P. D. Kwong and J. Sodroski (2010). "Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions." Mol Cell 37(5): 656-667.



Gavrilyuk, J., H. Uehara, N. Otsubo, A. Hessell, D. R. Burton and C. F. Barbas, 3rd (2010). "Potent inhibition of HIV-1 entry with a chemically programmed antibody aided by an efficient organocatalytic synthesis." Chembiochem 11(15): 2113-2118.



Gill, D. K., Y. Huang, G. L. Levine, A. Sambor, D. K. Carter, A. Sato, J. Kopycinski, P. Hayes, B. Hahn, J. Birungi, T. Tarragona-Fiol, H. Wan, M. Randles, A. R. Cooper, A. Ssemaganda, L. Clark, P. Kaleebu, S. G. Self, R. Koup, B. Wood, M. J. McElrath, J. H. Cox, J. Hural and J. Gilmour (2010). "Equivalence of ELISpot assays demonstrated between major HIV network laboratories." PLoS One 5(12): e14330.



Grant, R., J. Lama, P. Anderson, V. McMahan, A. Liu, L. Vargas, P. Goicochea, M. Casapia, J. Guanira-Carranza, M. Ramirez-Cardich, O. Montoya-Herrera, T. Fernandez, V. Veloso, S. Buchbinder, S. Chariyalertsak, M. Schechter, L. Bekker, K. Mayer, E. Kallas, K. Amico, K. Mulligan, L. Bushman, R. Hance, C. Ganoza, P. Defechereux, B. Postle, F. Wang, J. McConnell, J. Zheng and J. Lee (2010). "Preexposure chemoprophylaxis for HIV prevention in men who have sex with men." N Engl J Med 363: 2587 - 2599.



Hessell, A. J., E. G. Rakasz, D. M. Tehrani, M. Huber, K. L. Weisgrau, G. Landucci, D. N. Forthal, W. C. Koff, P. Poignard, D. I. Watkins and D. R. Burton (2010). "Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L." J Virol 84(3): 1302-1313.



Huber, M., K. M. Le, K. J. Doores, Z. Fulton, R. L. Stanfield, I. A. Wilson and D. R. Burton (2010). "Very few substitutions in a germ line antibody are required to initiate significant domain exchange." J Virol 84(20): 10700-10707.



Ingale, S., J. S. Gach, M. B. Zwick and P. E. Dawson (2010). "Synthesis and analysis of the membrane proximal external region epitopes of HIV-1." J Pept Sci 16(12): 716-722.



Jaoko, W., E. Karita, K. Kayitenkore, G. Omosa-Manyonyi, S. Allen, S. Than, E. M. Adams, B. S. Graham, R. A. Koup, R. T. Bailer, C. Smith, L. Dally, B. Farah, O. Anzala, C. M. Muvunyi, J. Bizimana, T. Tarragona-Fiol, P. J. Bergin, P. Hayes, M. Ho, K. Loughran, W. Komaroff, G. Stevens, H. Thomson, M. J. Boaz, J. H. Cox, C. Schmidt, J. Gilmour, G. J. Nabel, P. Fast and J. Bwayo (2010). "Safety and Immunogenicity Study of Multiclade HIV-1 Adenoviral Vector Vaccine Alone or as Boost following a Multiclade HIV-1 DNA Vaccine in Africa." PLoS One 5(9): e12873.



Khurana, S., P. J. Norris, M. P. Busch, B. F. Haynes, S. Park, P. Sasono, K. Mlisana, A. K. Salim, F. M. Hecht, J. Mulenga, E. Chomba, E. Hunter, S. Allen, G. Nemo, I. R. Rodriguez-Chavez, H. I. V. S. C. S. G. Women's Interagency, J. B. Margolick, A. C. S. Multicenter and H. Golding (2010). "HIV-Selectest enzyme immunoassay and rapid test: ability to detect seroconversion following HIV-1 infection." J Clin Microbiol 48(1): 281-285.



Koff, W. C. (2010). "Accelerating HIV vaccine development." Nature 464(7286): 161-162.



Kong, L., N. C. Sheppard, G. B. Stewart-Jones, C. L. Robson, H. Chen, X. Xu, G. Krashias, C. Bonomelli, C. N. Scanlan, P. D. Kwong, S. A. Jeffs, I. M. Jones and Q. J. Sattentau (2010). "Expression-system-dependent modulation of HIV-1 envelope glycoprotein antigenicity and immunogenicity." J Mol Biol 403(1): 131-147.



Krashias, G., A. K. Simon, F. Wegmann, W. L. Kok, L. P. Ho, D. Stevens, J. Skehel, J. L. Heeney, A. E. Moghaddam and Q. J. Sattentau (2010). "Potent adaptive immune responses induced against HIV-1 gp140 and influenza virus HA by a polyanionic carbomer." Vaccine 28(13): 2482-2489.



Lingappa, J. R., J. M. Baeten, A. Wald, J. P. Hughes, K. K. Thomas, A. Mujugira, N. Mugo, E. A. Bukusi, C. R. Cohen, E. Katabira, A. Ronald, J. Kiarie, C. Farquhar, G. J. Stewart, J. Makhema, M. Essex, E. Were, K. H. Fife, G. de Bruyn, G. E. Gray, J. A. McIntyre, R. Manongi, S. Kapiga, D. Coetzee, S. Allen, M. Inambao, K. Kayitenkore, E. Karita, W. Kanweka, S. Delany, H. Rees, B. Vwalika, A. S. Magaret, R. S. Wang, L. Kidoguchi, L. Barnes, R. Ridzon, L. Corey, C. Celum and H. S. V. H. I. V. T. S. T. Partners in Prevention (2010). "Daily acyclovir for HIV-1 disease progression in people dually infected with HIV-1 and herpes simplex virus type 2: a randomised placebo-controlled trial." Lancet 375(9717): 824-833.



Luallen, R. J., C. Agrawal-Gamse, H. Fu, D. F. Smith, R. W. Doms and Y. Geng (2010). "Antibodies against Manalpha1,2-Manalpha1,2-Man oligosaccharide structures recognize envelope glycoproteins from HIV-1 and SIV strains." Glycobiology 20(3): 280-286.



Lynch, R. M., R. Rong, B. Li, T. Shen, W. Honnen, J. Mulenga, S. Allen, A. Pinter, S. Gnanakaran and C. A. Derdeyn (2010). "Subtype-specific conservation of isoleucine 309 in the envelope V3 domain is linked to immune evasion in subtype C HIV-1 infection." Virology 404(1): 59-70.



Mascola, J. R. and D. C. Montefiori (2010). "The role of antibodies in HIV vaccines." Annu Rev Immunol 28: 413-444.



Miura, T., Z. L. Brumme, M. A. Brockman, P. Rosato, J. Sela, C. J. Brumme, F. Pereyra, D. E. Kaufmann, A. Trocha, B. L. Block, E. S. Daar, E. Connick, H. Jessen, A. D. Kelleher, E. Rosenberg, M. Markowitz, K. Schafer, F. Vaida, A. Iwamoto, S. Little and B. D. Walker (2010). "Impaired replication capacity of acute/early viruses in persons who become HIV controllers." J Virol 84(15): 7581-7591.



Moser, J. M., E. R. Sassano, C. Leistritz del, J. M. Eatrides, S. Phogat, W. Koff and D. R. Drake, 3rd (2010). "Optimization of a dendritic cell-based assay for the in vitro priming of naive human CD4+ T cells." J Immunol Methods 353(1-2): 8-19.



Mouquet, H., J. F. Scheid, M. J. Zoller, M. Krogsgaard, R. G. Ott, S. Shukair, M. N. Artyomov, J. Pietzsch, M. Connors, F. Pereyra, B. D. Walker, D. D. Ho, P. C. Wilson, M. S. Seaman, H. N. Eisen, A. K. Chakraborty, T. J. Hope, J. V. Ravetch, H. Wardemann and M. C. Nussenzweig (2010). "Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation." Nature 467(7315): 591-595.



Ng, C. T., J. P. Jaworski, P. Jayaraman, W. F. Sutton, P. Delio, L. Kuller, D. Anderson, G. Landucci, B. A. Richardson, D. R. Burton, D. N. Forthal and N. L. Haigwood (2010). "Passive neutralizing antibody controls SHIV viremia and enhances B cell responses in infant macaques." Nat Med 16(10): 1117-1119.



O'Connor, S. L., J. J. Lhost, E. A. Becker, A. M. Detmer, R. C. Johnson, C. E. Macnair, R. W. Wiseman, J. A. Karl, J. M. Greene, B. J. Burwitz, B. N. Bimber, S. M. Lank, J. J. Tuscher, E. T. Mee, N. J. Rose, R. C. Desrosiers, A. L. Hughes, T. C. Friedrich, M. Carrington and D. H. O'Connor (2010). "MHC heterozygote advantage in simian immunodeficiency virus-infected Mauritian cynomolgus macaques." Sci Transl Med 2(22): 22ra18.



Ofek, G., F. J. Guenaga, W. R. Schief, J. Skinner, D. Baker, R. Wyatt and P. D. Kwong (2010). "Elicitation of structure-specific antibodies by epitope scaffolds." Proc Natl Acad Sci U S A 107(42): 17880-17887.



Ofek, G., K. McKee, Y. Yang, Z. Y. Yang, J. Skinner, F. J. Guenaga, R. Wyatt, M. B. Zwick, G. J. Nabel, J. R. Mascola and P. D. Kwong (2010). "Relationship between antibody 2F5 neutralization of HIV-1 and hydrophobicity of its heavy chain third complementarity-determining region." J Virol 84(6): 2955-2962.



Pancera, M., S. Majeed, Y. E. Ban, L. Chen, C. C. Huang, L. Kong, Y. D. Kwon, J. Stuckey, T. Zhou, J. E. Robinson, W. R. Schief, J. Sodroski, R. Wyatt and P. D. Kwong (2010). "Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility." Proc Natl Acad Sci U S A 107(3): 1166-1171.



Pancera, M., J. S. McLellan, X. Wu, J. Zhu, A. Changela, S. D. Schmidt, Y. Yang, T. Zhou, S. Phogat, J. R. Mascola and P. D. Kwong (2010). "Crystal structure of PG16 and chimeric dissection with somatically related PG9: structure-function analysis of two quaternary-specific antibodies that effectively neutralize HIV-1." J Virol 84(16): 8098-8110.



Pejchal, R., L. M. Walker, R. L. Stanfield, S. K. Phogat, W. C. Koff, P. Poignard, D. R. Burton and I. A. Wilson (2010). "Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1." Proc Natl Acad Sci U S A 107(25): 11483-11488.



Pejchal, R. and I. A. Wilson (2010). "Structure-based vaccine design in HIV: blind men and the elephant?" Curr Pharm Des 16(33): 3744-3753.



Pietzsch, J., J. F. Scheid, H. Mouquet, M. S. Seaman, C. C. Broder and M. C. Nussenzweig (2010). "Anti-gp41 antibodies cloned from HIV-infected patients with broadly neutralizing serologic activity." J Virol 84(10): 5032-5042.



Reynolds, M. R., A. M. Weiler, S. M. Piaskowski, H. L. Kolar, A. J. Hessell, M. Weiker, K. L. Weisgrau, E. J. Leon, W. E. Rogers, R. Makowsky, A. B. McDermott, R. Boyle, N. A. Wilson, D. B. Allison, D. R. Burton, W. C. Koff and D. I. Watkins (2010). "Macaques vaccinated with simian immunodeficiency virus SIVmac239Delta nef delay acquisition and control replication after repeated low-dose heterologous SIV challenge." J Virol 84(18): 9190-9199.




Ruzagira, E., A. Abaasa, J. Levin, U. Bahemuka, A. Bwanika, P. N. Amornkul, M. A. Price, H. Grosskurth and A. Kamali (2010). "Haematological and biochemistry laboratory abnormalities associated with splenomegaly in asymptomatic adults in Masaka, Uganda: implications for HIV biomedical prevention trials." Trop Med Int Health 15(1): 105-112.



Sanders, E. J., A. N. Thiong'o, H. S. Okuku, J. Mwambi, F. Priddy, J. Shafi, H. de Vries, R. S. McClelland and S. M. Graham (2010). "High prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae infections among HIV-1 negative men who have sex with men in coastal Kenya." Sex Transm Infect 86(6): 440-441.



Spentzou, A., P. Bergin, D. Gill, H. Cheeseman, A. Ashraf, H. Kaltsidis, M. Cashin-Cox, I. Anjarwalla, A. Steel, C. Higgs, A. Pozniak, A. Piechocka-Trocha, J. Wong, O. Anzala, E. Karita, L. Dally, F. Gotch, B. Walker, J. Gilmour and P. Hayes (2010). "Viral inhibition assay: a CD8 T cell neutralization assay for use in clinical trials of HIV-1 vaccine candidates." J Infect Dis 201(5): 720-729.



Stansell, E. and R. C. Desrosiers (2010). "Fundamental difference in the content of high-mannose carbohydrate in the HIV-1 and HIV-2 lineages." J Virol 84(18): 8998-9009.



Stephenson, R., K. Grabbe, B. Vwalika, Y. Ahmed, C. Vwalika, A. Haworth, L. Fuller, F. Liu, E. Chomba and S. Allen (2010). "The influence of informed consent content on study participants' contraceptive knowledge and concerns." Stud Fam Plann 41(3): 217-224.



Sundling, C., M. N. Forsell, S. O'Dell, Y. Feng, B. Chakrabarti, S. S. Rao, K. Lore, J. R. Mascola, R. T. Wyatt, I. Douagi and G. B. Karlsson Hedestam (2010). "Soluble HIV-1 Env trimers in adjuvant elicit potent and diverse functional B cell responses in primates." J Exp Med 207(9): 2003-2017.



Tang, J., R. Malhotra, W. Song, I. Brill, L. Hu, P. K. Farmer, J. Mulenga, S. Allen, E. Hunter and R. A. Kaslow (2010). "Human leukocyte antigens and HIV type 1 viral load in early and chronic infection: predominance of evolving relationships." PLoS One 5(3): e9629.



Tilton, J. C., H. Amrine-Madsen, J. L. Miamidian, K. M. Kitrinos, J. Pfaff, J. F. Demarest, N. Ray, J. L. Jeffrey, C. C. Labranche and R. W. Doms (2010). "HIV type 1 from a patient with baseline resistance to CCR5 antagonists uses drug-bound receptor for entry." AIDS Res Hum Retroviruses 26(1): 13-24.



Tovanabutra, S., E. J. Sanders, S. M. Graham, M. Mwangome, N. Peshu, R. S. McClelland, A. Muhaari, J. Crossler, M. A. Price, J. Gilmour, N. L. Michael and F. M. McCutchan (2010). "Evaluation of HIV type 1 strains in men having sex with men and in female sex workers in Mombasa, Kenya." AIDS Res Hum Retroviruses 26(2): 123-131.



Vardas, E., P. Kaleebu, L. G. Bekker, A. Hoosen, E. Chomba, P. R. Johnson, P. Anklesaria, J. Birungi, B. Barin, M. Boaz, J. Cox, J. Lehrman, G. Stevens, J. Gilmour, T. Tarragona, P. Hayes, S. Lowenbein, E. Kizito, P. Fast, A. E. Heald and C. Schmidt (2010). "A phase 2 study to evaluate the safety and immunogenicity of a recombinant HIV type 1 vaccine based on adeno-associated virus." AIDS Res Hum Retroviruses 26(8): 933-942.



Vasan, S., S. J. Schlesinger, Z. Chen, A. Hurley, A. Lombardo, S. Than, P. Adesanya, C. Bunce, M. Boaz, R. Boyle, E. Sayeed, L. Clark, D. Dugin, M. Boente-Carrera, C. Schmidt, Q. Fang, LeiBa, Y. Huang, G. J. Zaharatos, D. F. Gardiner, M. Caskey, L. Seamons, M. Ho, L. Dally, C. Smith, J. Cox, D. Gill, J. Gilmour, M. C. Keefer, P. Fast and D. D. Ho (2010). "Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine." PLoS One 5(1): e8816.



Vasan, S., S. J. Schlesinger, Y. Huang, A. Hurley, A. Lombardo, Z. Chen, S. Than, P. Adesanya, C. Bunce, M. Boaz, R. Boyle, E. Sayeed, L. Clark, D. Dugin, C. Schmidt, Y. Song, L. Seamons, L. Dally, M. Ho, C. Smith, M. Markowitz, J. Cox, D. K. Gill, J. Gilmour, M. C. Keefer, P. Fast and D. D. Ho (2010). "Phase 1 Safety and Immunogenicity Evaluation of ADVAX, a Multigenic, DNA-Based Clade C/B' HIV-1 Candidate Vaccine." PLoS ONE 5(1): e8617.



Voronin, Y. and S. Phogat (2010). "HIV/AIDS: vaccines and alternate strategies for treatment and prevention." Ann N Y Acad Sci 1205 Suppl 1: E1-9.



Walker, L. M. and D. R. Burton (2010). "Rational antibody-based HIV-1 vaccine design: current approaches and future directions." Curr Opin Immunol 22(3): 358-366.



Walker, L. M., M. D. Simek, F. Priddy, J. S. Gach, D. Wagner, M. B. Zwick, S. K. Phogat, P. Poignard and D. R. Burton (2010). "A limited number of antibody specificities mediate broad and potent serum neutralization in selected HIV-1 infected individuals." PLoS Pathog 6(8): e1001028.



Wallis, C. L., M. A. Papathanasopoulos, S. Lakhi, E. Karita, A. Kamali, P. Kaleebu, E. Sanders, O. Anzala, L. G. Bekker, G. Stevens, T. F. de Wit and W. Stevens (2010). "Affordable in-house antiretroviral drug resistance assay with good performance in non-subtype B HIV-1." J Virol Methods 163(2): 505-508.



Wayne, C. K. and S. F. Berkley (2010). "The renaissance in HIV vaccine development--future directions." N Engl J Med 363(5): e7.



Xiang, S. H., A. Finzi, B. Pacheco, K. Alexander, W. Yuan, C. Rizzuto, C. C. Huang, P. D. Kwong and J. Sodroski (2010). "A V3 loop-dependent gp120 element disrupted by CD4 binding stabilizes the human immunodeficiency virus envelope glycoprotein trimer." J Virol 84(7): 3147-3161.



Xu, R., D. C. Ekiert, J. C. Krause, R. Hai, J. E. Crowe, Jr. and I. A. Wilson (2010). "Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus." Science 328(5976): 357-360.